Prostate Cancer Treatment Success Rates in India: What Nigerian Patients Should Know

Considering prostate cancer treatment in India? Learn about survival rates, robotic surgery, radiation, hormone therapy and costs for Nigerian patients.
Published on 19 October 20268m
Adil Hussain

Adil Hussain

Health and Wellness Writer and Senior Manager, Content Development at TMTC

Prostate Cancer Treatment Success Rates in India: What Nigerian Patients Should Know
It often begins with a single result: a high PSA test, a biopsy report, a urologist in Lagos or Abuja who pauses before saying prostate cancer. In that pause, most men hear one question: what happens to me now?
If you or someone you love is living inside that question, you deserve real answers, not unsourced numbers. Prostate cancer is the most common cancer in Nigerian men, yet when found early it is one of the most treatable cancers there is. This guide explains prostate cancer survival rates, what shapes cancer treatment outcomes, and what prostate cancer treatment in India for Nigerian patients involves. Take a look.

Why Prostate Cancer Hits Nigerian Men So Hard

The figures below can feel heavy, so hold on to this first: caught early, prostate cancer is one of the most treatable cancers there is, and the reasons it hits Nigerian men so hard are well understood, which means they can be changed.
Prostate cancer is the most common cancer in Nigerian men. In 2022, an estimated 18,019 men heard that diagnosis, and 11,443 lost their lives to it (Global Cancer Observatory). Three things drive that toll, and each one can be addressed.
A higher risk to begin with. Prostate cancer is more likely in Black men and in men with a family history of the disease. In the US, Black men are diagnosed at about 1.6 times the national rate and die of prostate cancer at nearly twice the rate (SEER).
Diagnosis comes too late. A ten-year study in south-eastern Nigeria found 81.4% of men presented late, and 62% already had cancer that had spread. In a survey of Nigerian urologists, 95.4% of their prostate cancer patients were diagnosed at an advanced stage (Nigerian Journal of Clinical Practice).
Little routine screening. Nigeria has no formal programme targeting prostate cancer, and 90.9% of the urologists surveyed knew of no national screening guideline (Nigerian Journal of Clinical Practice). Without screening, most men are diagnosed only after symptoms appear, when the cancer has often already spread.

Prostate Cancer Survival Rates by Stage

The most detailed recent Indian figures come from a leading hospital in Mumbai. Researchers followed 421 men for five years after they began treatment in 2017. These are five-year overall survival rates: the share of men still alive five years later, counting deaths from any cause, not only prostate cancer. The men's average age was 66, so some deaths came from other illnesses. These figures describe large groups and cannot predict one man's outcome.
Stage at diagnosisWhat it means5-year overall survival
LocalizedConfined to the prostate89%
Locally AdvancedGrown beyond the prostate or into nearby lymph nodes79%
MetastaticSpread to bone or distant organs41%
All stagesEvery man in the study61%
Source: Tata Memorial Hospital, Mumbai. Men diagnosed in 2017 and followed to 2022 (BJUI Compass, 2026).
The figure for all stages is pulled down by when the men were diagnosed. Most of them were diagnosed before the cancer reached bone or distant organs, and more than half had cancer that had spread. That is the same late-diagnosis pattern Nigerian men face.
The study also shows what patients and their families can influence. Men who completed their full treatment had a 65% five-year survival rate, compared with 12% for those who stopped early. Even after accounting for stage, stopping treatment more than tripled the risk of death (BJUI Compass). The most important number for any man is how soon he is tested. The second is whether he finishes the treatment he starts.

What Shapes Your Cancer Treatment Outcomes

Beyond stage, specialists weigh several factors before recommending any prostate cancer treatment:
  • PSA level and trend, which flags cancer early and tracks it after treatment.
  • Gleason score or Grade Group, which shows how aggressive the cells are.
  • Age and general health, which decide which treatments are safe for you.
  • Your hospital's experience, the factor patients most often underestimate.
That last point is backed by international research. A JAMA Network Open study of 1,899 men treated with radiation therapy and hormone therapy found median survival of 111.1 months at high-volume centres against 92.3 months at low-volume ones (PubMed). This is why TMTC places Nigerian patients with teams at high-volume Indian hospitals that perform these procedures routinely.

Treatment Options: Robotic Surgery, Radiation Therapy and Hormone Therapy

For localized disease, the main options lead to similar survival: in ProtecT, 15-year prostate cancer survival was 97.2% after surgery and 97.7% after radiation therapy (ASCO Post). The choice often comes down to side effects, recovery and your priorities.
Robotic surgery removes the prostate through small incisions with magnified 3D vision, aiming to control the cancer while preserving urinary and sexual function. Most men stay in hospital two to three days and return to desk work within four to six weeks.
Radiation therapy, including IMRT, SBRT and brachytherapy, targets the prostate while sparing nearby organs. It avoids an operation, but a conventional course means daily sessions over six to eight weeks.
Hormone therapy lowers testosterone to slow cancer growth. It is used alongside radiation therapy, for advanced or metastatic disease, and when cancer returns. Even when cancer has spread, it can often be controlled for years.

What Prostate Cancer Treatment in India Costs

TreatmentPrivate care in Nigeria (USD)India (USD)
Robotic surgery (robotic prostatectomy)15,000–25,0006,000–8,500
Radiation therapy (full course)8,000–15,0003,500–5,000
Brachytherapy12,000–18,0004,000–6,000
These are planning ranges, not quotes. Even after flights and accommodation, total costs are often well below equivalent private care in Nigeria. Hormone therapy and radiation therapy plans are priced once a specialist has reviewed your staging.

How TMTC Supports You

Good cancer treatment outcomes depend on more than the operating theatre. The Medical Travel Company (TMTC) has your reports reviewed by an Indian uro-oncology team before you travel, so you arrive with a plan and a written estimate. We handle visa support, flights, accommodation and admission at JCI- and NABH-accredited hospitals. You return home with your full medical file and a PSA follow-up schedule, and we stay connected with your case, because regular PSA testing is how any recurrence is caught early.

Your Next Step

A prostate cancer diagnosis asks a lot of a man and his family, but it should not be faced with half the facts. If you are weighing prostate cancer treatment in India, share your PSA, biopsy and scan reports with the TMTC care team. We will help you understand your stage, your options, and the outcomes you can realistically expect.

Sources

Ready to open the door to better health?

Decorative Underline Accent TMTC
Get in Touch Image TMTC